SCHEMBL3581336

SCHEMBL3581336

CCCCc1ccc(N=Nc2ccc(N=Cc3ccc(N=Nc4ccc(N(CC)CC)cc4)cc3)c(C)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.46
CYP2D6 P10635 4/20 0.46
CYP2C9 P11712 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
CYP4Z1 Q86W10 1/20 0.46
CYP4F11 Q9HBI6 1/20 0.46
CYP4F12 Q9HCS2 1/20 0.46
ALDH1A1 P00352 12/20 0.42
MAPT P10636 11/20 0.42
RAB9A P51151 5/20 0.42
KDM4E B2RXH2 4/20 0.39
GAA P10253 3/20 0.39
NPC1 O15118 3/20 0.38
TDP1 Q9NUW8 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 3/20 0.37
KMT2A Q03164 3/20 0.37
GRIN2D O15399 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23136948 1.00 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL3623142 0.94 CYP3A4 (0.41) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL3583242 0.93 ALDH1A1 (0.43) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL23136947 0.93 ALDH1A1 (0.43) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL14946511 0.91 CYP3A4 (0.40) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL10269730 0.90 CYP3A4 (0.42) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL16125397 0.87 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL10215989 0.87 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL10216442 0.87 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C9CYP1A2CYP2C19
SCHEMBL10163986 0.87 ALDH1A1 (0.41) ALDH1A1MAPTRAB9AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10280181-B2 Coloring composition, anisotropic light absorption film, laminate, polarizing plate, image display device and compound FUJIFILM CORPORATION (JP) 2019-05-07 US disclosed
US-20160340367-A1 COLORING COMPOSITION, ANISOTROPIC LIGHT ABSORPTION FILM, LAMINATE, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2016-11-24 US disclosed
US-20160340367-A1 COLORING COMPOSITION, ANISOTROPIC LIGHT ABSORPTION FILM, LAMINATE, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2016-11-24 US disclosed
US-20160280999-A1 POLARIZING FILM, DISPLAY DEVICE AND PRODUCTION PROCESS THEREOF FUJIFILM CORPORATION (JP) 2016-09-29 US disclosed
US-9382481-B2 Polarizing film, display device and production process thereof FUJIFILM CORPORATION (JP) 2016-07-05 US disclosed
US-9011988-B2 Liquid-crystal compound, liquid-crystal composition, light absorption anisotropic film, and liquid-crystal display device FUJIFILM CORPORATION (JP) 2015-04-21 US disclosed
US-8927070-B2 Dichroic dye composition, light absorption anisotropic film, and polarizing element FUJIFILM CORPORATION (JP) 2015-01-06 US disclosed
US-8865275-B2 Light absorption anisotropic film, polarizing film, process for producing the polarizing film and display device using the polarizing film FUJIFILM CORPORATION (JP) 2014-10-21 US disclosed
US-8728976-B2 Printing paper for printing stereoscopic image, stereoscopic image printed matter, and method for providing stereoscopic image FUJIFILM CORPORATION (JP) 2014-05-20 US disclosed
US-8623476-B2 Polarizing element and method of producing the same FUJIFILM CORPORATION (JP) 2014-01-07 US disclosed
US-20130169896-A1 STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2013-07-04 US disclosed
US-20130120676-A1 STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2013-05-16 US disclosed
US-20130120676-A1 STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2013-05-16 US disclosed
US-20130083276-A1 PRINTING SHEET FOR PRINTING STEREO PICTURE, STEREO PICTURE PRINT, METHOD OF MANUFACTURING STEREO PICTURE PRINT, AND METHOD OF PROVIDING STEREO PICTURE FUJIFILM CORPORATION (JP) 2013-04-04 US disclosed
US-20120107530-A1 Printing paper for printing stereoscopic image, stereoscopic image printed matter, and method for providing stereoscopic image FUJIFILM CORPORATION (JP) 2012-05-03 US disclosed
US-20120099054-A1 COLOR FILTER AND LIGHT-EMITTING DISPLAY ELEMENT UDC IRELAND LIMITED (IE) 2012-04-26 US disclosed
US-20110177315-A1 DICHROIC DYE COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, AND POLARIZING ELEMENT FUJIFILM CORPORATION (JP) 2011-07-21 US disclosed
US-20110051052-A1 POLARIZING FILM, LAMINATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20100182543-A1 LIQUID CRYSTALLINE COMPOSITION AND LIGHT ABSORPTION ANISOTROPIC FILM, A POLARIZING ELEMENT AND A LIQUID CRYSTAL DISPLAY DEVICE, EACH EMPLOYING THE SAME FUJIFILM CORPORATION (JP) 2010-07-22 US disclosed
US-20100134726-A1 POLARIZING ELEMENT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340367-A1 COLORING COMPOSITION, ANISOTROPIC LIGHT ABSORPTION FILM, LAMINATE, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND COMPOUND AHR, CTNNA1, HTR1D CYP3A4 228/4885CYP2D6 356/4885CYP2C9 440/4885
US-10280181-B2 Coloring composition, anisotropic light absorption film, laminate, polarizing plate, image display device and compound AHR, CTNNA1, HTR1D CYP3A4 228/4885CYP2D6 356/4885CYP2C9 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.